Raymond James & Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.71M | Buy |
|
|||||
|
2021
Q2 | $3M | Buy |
|
|||||
|
2021
Q1 | $1.79M | Buy |
|
|||||
|
2020
Q4 | $2.29M | Sell |
|
|||||
|
2020
Q3 | $2.26M | Sell |
|
|||||
|
2020
Q2 | $2.93M | Sell |
|
|||||
|
2020
Q1 | $1.86M | Buy |
|
|||||
|
2019
Q4 | $2.98M | Sell |
|
|||||
|
2019
Q3 | $2.35M | Sell |
|
|||||
|
2019
Q2 | $2.72M | Buy |
|
|||||
|
2019
Q1 | $2.49M | Buy |
|
|||||
|
2018
Q4 | $1.55M | Sell |
|
|||||
|
2018
Q3 | $3.52M | Buy |
|
|||||
|
2018
Q2 | $4.35M | Sell |
|
|||||
|
2018
Q1 | $4.51M | Sell |
|
|||||
|
2017
Q4 | $5.23M | Buy |
|
|||||
|
2017
Q3 | $3M | Buy |
|
|||||
|
2017
Q2 | $2.43M | Buy |
|
|||||
|
2017
Q1 | $1.71M | Buy |
|
|||||
|
2016
Q4 | $390K | Buy |
|